Navigation Links
Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
Date:10/29/2010

ective tax rate in 2010 was lower than 2009 as the Non GAAP rate in Q3 2009 was adversely impacted by the initial recognition of valuation allowances against certain EU deferred tax assets and increases to accrued interest on tax contingencies, which resulted in charges not repeated in Q3 2010.

The US GAAP effective rate of tax in Q3 2010 was 11 percentage points higher than the Non GAAP effective tax rate as certain items excluded from Non GAAP income, such as the up-front payment to Acceleron and the write-down of the DAYTRANA intangible asset, were either made from territories with tax rates lower than Shire's effective rate or in territories where the establishment of valuation allowances precluded the recognition of any tax benefit.

FINANCIAL INFORMATION TABLE OF CONTENTS Page Unaudited US GAAP Consolidated Balance Sheets 13 Unaudited US GAAP Consolidated Statements of Income 14 Unaudited US GAAP Consolidated Statements of Cash Flows 16 Selected Notes to the Unaudited US GAAP Financial Statements (1) Earnings per share 18 (2) Analysis of revenues 19 Non GAAP reconciliation 21

Unaudited US GAAP results for the three months and nine months to September 30, 2010 Consolidated Balance Sheets

September 30, December 31, 2010 2009 $M $M ASSETS Current assets: Cash and cash equivalents 193.3 498.9 Restricted cash 605.1 33.1 Accounts receivable, net 722.1 597.5 Inventories 252.6 189.7 Assets held for sale 61.5 1.7 Deferred tax asset 145.8 135.8 Prepaid expenses and other current assets 179.6 113.5 Total current assets 2,160.0 1,570.2 Non-current assets: Investments 89.1 105.7 Property, plant and equipment, net 818.6 676.8 Goodwill 375.0 384.7 Other intangible assets, net 1,567.2 1,790.7 Deferred tax asset 86.3 79.0 Other non-current assets 5.4 10.4 Total assets 5,101.6 4,617.5 LIABILITIES AND EQUITY Current liabilities: Accounts payable and accrued expenses 1,098.1 929.1 Deferred tax liability 2.9 2.9 Other current liabilities 70.2 88.0
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
2. Reportlinker Adds Shire plc: PharmaVitae Profile
3. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
4. Shire plc - Statement re ProAmatine
5. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
6. Lialda(R) - Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
7. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
8. Shire plc Appoints Two New Board Directors
9. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
10. Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection)
11. INTUNIV(TM) - Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... CAMBRIDGE, England , July 29, 2014 ... das Liquid Biopsy System (LBS) zur Erfassung ... an den Herzkranzgefäßen entwickelt und patentiert. Das ... Stellen innerhalb der Koronararterie des Patienten und ... Das LBS hat das Potenzial, die Entdeckung ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According ... Transparency Market Research "Regenerative Medicine (Bone and Joint) ... and Tissue Engineering; By Applications - Bone Graft ... Others) - Global Industry Analysis, Size, Share, Growth, ... regenerative medicine (bone and joint) market was valued ...
(Date:7/28/2014)... 2014  David Hardison, Ph.D., vice president of ... has been elected chairman of the board for ... working to establish common protocols around the use ... to electronic health records. Hardison ... with organizations across the research and health care ...
(Date:7/28/2014)... The global market for biotechnology is expected ... a new study by Grand View Research, Inc. Increasing ... vaccines and drugs in an attempt to improve healthcare ... to drive market demand over the next six years. ... the use of genetically engineered seeds is expected to ...
Breaking Biology Technology:PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 4Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4
... Oct. 17 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ... 2007 financial results on Wednesday, October 24,2007 after the ... a,conference call at 5:00 p.m. ET, which will be ... conference call, the company will review,the financial results and ...
... ST. LOUIS, Oct. 17 Monsanto Company (NYSE:,MON) ... Hugh Grant,chairman, president and chief executive officer, and ... have established stock trading,plans in accordance with Rule ... Under these plans, the Monsanto executives have directed ...
... today that,the Henry C. Witelson Ocular Pathology Laboratory ... Personal Archive biosample management system.,The laboratory is located ... a critical component of the Laboratory,s,research in determining ... and retinoblastoma and for developing new approaches for,treatment. ...
Cached Biology Technology:Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast 2McGill University Purchases GenVault's Personal Archive System to Manage Rare Cancer Samples 2
(Date:7/28/2014)... himself the bug hunter, but the target of his ... and identified with special methods and instruments. Benjamin Hause, ... Diagnostic Laboratory at Kansas State University, recently published an ... which is an important find in the United States. ... didn,t know what it was," Hause said. "We used ...
(Date:7/28/2014)... , July 28, 2014 Research and ... "Biometrics Market in Latin America 2014-2018" report to ... Biometrics measure and analyze biological data. These ... irises, eye retinas, voice patterns, and hand measurements from ... more stored templates. The main purpose of a biometrics ...
(Date:7/28/2014)... Norwegian explorer Roald Amundsen became the first man ... More than 100 years later, an international team of ... Institute (DRI) have proven that air pollution from industrial ... ice cores collected from widely spaced locations around the ... the most accurate and precise reconstruction to date of ...
Breaking Biology News(10 mins):Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3Biometrics Market in Latin America 2014-2018 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... Chinese hybrid rice genome, which was published in the Journal ... map of the rice genome. In an article published by ... scientists led by the Beijing Institute of Genomics (BIG) reported ... japonica subspecies of O. sativa." , The fine maps of ...
... an important molecular signaling mechanism whose existence has been,known, ... since the,identification of a mutant strain of Drosophila fruit ... Later studies,revealed that the Notch gene encodes a receptor ... and which is capable of,interacting with a ligand partner, ...
... new research indicates that it may all come down ... University scientists who had previously identified a key gene ... now shows that this gene's function appears to be ... by Leslie Vosshall's laboratory had previously shown that of ...
Cached Biology News:Whole genome fine map of rice completed 2Bound for destruction: Ubiquitination protects against improper Notch signaling 2Bound for destruction: Ubiquitination protects against improper Notch signaling 3Ancient olfaction protein is shared by many bugs, offering new pest control target 2
... 3B8A10. Immunogen: Recombinant ... C-terminal region of human ... for the human ubiquilin ... (positive control: 293 cells). ...
...
...
... I-96 Plate can be used either in ... large-scale (i.e., 96-well) purification of DNA and/or ... unique silica-based matrix make it perfect for ... RNA in = 10 l eluate per ...
Biology Products: